Business

Belgian over the counter (OTC) specialist Omega Pharma has acquired several OTC products from GSK, including Beconase beclomethasone nasal spray. The deal, which also includes brands Lactacyd, Abtei, Solpadeine, Zantac, and Nytol totaled €470 million… Read more . . .

AstraZeneca has entered into a multi-year agreement with Galapagos subsidiaries BioFocus and Argenta to collaborate on discovery of compounds for the treatment of respiratory and inflammatory diseases. The deal allows AstraZeneca the use of Argenta’s… Read more . . .

Alexza Pharmaceuticals, whose lead product, Adasuve Staccato loxapine is under review by the FDA and the EMA, has reported a net loss of $40.5 million for the year ended December 31, 2011. The company also… Read more . . .

Nycomed says that it is now marketing its Omnaris ciclesonide nasal spray for the treatment of allergic rhinitis in the United Arab Emirates (UAE). The company, a subsidiary of Takeda, says that it will launch… Read more . . .

Specialty pharmaceutical manufacturer Hi-Tech Pharmacal will pay a total of $2.5 million plus up to to $1.75 million in royalties to Dynova Laboratories for a line of homeopathic nasal sprays including the Sinus Buster and… Read more . . .

On March 1, Judge John Koeltl of the US District Court for the Southern District of New York issued a partial summary judgment in Mylan’s patent infringement suit against Sunovion Pharmaceuticals, invalidating 5 of the… Read more . . .

A company called GSC Products has launched what it says is “the world’s first caffeine nasal spray” in the US. GSC says that the product, called Turbo Snort, was introduced on the Internet in January… Read more . . .

Aradigm has announced that the United States Patent and Trademark Office has issued an additional patent covering several formulations of ciprofloxacin, including the company’s lead product, Pulmaquin dual release ciprofloxacin for inhalation. The patent (US… Read more . . .

Irish nebulizer manufacturer Aerogen has received authorization from the Chinese State Food and Drug Administration (SFDA) to market its Aeroneb Pro and Aeroneb Go vibrating mesh nebulizers in China. The company expects to begin selling… Read more . . .